celastrol has been researched along with snx 2112 in 1 studies
| Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) | Studies (snx 2112) | Trials (snx 2112) | Recent Studies (post-2010) (snx 2112) |
|---|---|---|---|---|---|
| 885 | 1 | 741 | 58 | 1 | 49 |
| Protein | Taxonomy | celastrol (IC50) | snx 2112 (IC50) |
|---|---|---|---|
| Corticotropin releasing hormone receptor 2 | Sus scrofa (pig) | 0.002 | |
| Heat shock protein HSP 90-alpha | Homo sapiens (human) | 1.2645 | |
| Heat shock protein HSP 90-beta | Homo sapiens (human) | 1.1262 | |
| Endoplasmin | Canis lupus familiaris (dog) | 0.531 | |
| Heat shock protein 75 kDa, mitochondrial | Homo sapiens (human) | 0.7585 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L; Wang, L; Xu, XL; You, QD | 1 |
1 review(s) available for celastrol and snx 2112
| Article | Year |
|---|---|
Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions.
Topics: Animals; Antineoplastic Agents; Autoimmune Diseases; Benzoquinones; Forecasting; HSP90 Heat-Shock Proteins; Humans; Immunosuppressive Agents; Lactams, Macrocyclic; Molecular Chaperones; Neoplasms; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary | 2020 |